Key result
Capadenoson blunted stress-induced tachycardia by 45% in Spontaneously Hypertensive Rats compared to vehicle, but had no effect in Wistar rats.
Why the study?
Does capadenoson reduce norepinephrine release and stress-induced heart rate increase in Wistar and Spontaneously Hypertensive Rats?
Does capadenoson reduce norepinephrine release and stress-induced heart rate increase in Wistar and Spontaneously Hypertensive Rats?
Effect estimate: 45% reduction
Absolute Event Rate: 20% vs 36%
p-value: p=0.001
Partial adenosine A1-agonism with capadenoson selectively dampens stress-induced tachycardia and norepinephrine release in rats with high baseline sympathetic activity.
May support selective A1 agonism for sympathetic modulation in hypertension; leaves open translation to human stress tachycardia.
The release of the neurotransmitter norepinephrine (NE) is modulated by presynaptic adenosine receptors. In the present study we investigated the effect of a partial activation of this feedback mechanism. We hypothesized that partial agonism would have differential effects on NE release in isolated hearts as well as on heart rate in vivo depending on the genetic background and baseline sympathetic activity. In isolated perfused hearts of Wistar and Spontaneously Hypertensive Rats (SHR), NE release was induced by electrical stimulation under control conditions (S1), and with capadenoson 6 · 10(-8) M (30 µg/l), 6 · 10(-7) M (300 µg/l) or 2-chloro-N(6)-cyclopentyladenosine (CCPA) 10(-6) M (S2). Under control conditions (S1), NE release was significantly higher in SHR hearts compared to Wistar (766+/-87 pmol/g vs. 173+/-18 pmol/g, p<0.01). Capadenoson led to a concentration-dependent decrease of the stimulation-induced NE release in SHR (S2/S1 = 0.90 ± 0.08 with capadenoson 6 · 10(-8) M, 0.54 ± 0.02 with 6 · 10(-7) M), but not in Wistar hearts (S2/S1 = 1.05 ± 0.12 with 6 · 10(-8) M, 1.03 ± 0.09 with 6 · 10(-7) M). CCPA reduced NE release to a similar degree in hearts from both strains. In vivo capadenoson did not alter resting heart rate in Wistar rats or SHR. Restraint stress induced a significantly greater increase of heart rate in SHR than in Wistar rats. Capadenoson blunted this stress-induced tachycardia by 45% in SHR, but not in Wistar rats. Using a [(35)S]GTPγS assay we demonstrated that capadenoson is a partial agonist compared to the full agonist CCPA (74+/-2% A(1)-receptor stimulation). These results suggest that partial adenosine A(1)-agonism dampens stress-induced tachycardia selectively in rats susceptible to strong increases in sympathetic activity, most likely due to a presynaptic attenuation of NE release.
No takes yet. Share an insight, caveat, or question.
Bott‐Flügel et al. (2011) studied Stress-induced tachycardia (n=96). Capadenoson vs. Vehicle was evaluated on Relative increase in heart rate during restraint stress in Spontaneously Hypertensive Rats (45% reduction, p=0.001). Capadenoson blunted stress-induced tachycardia by 45% in Spontaneously Hypertensive Rats compared to vehicle, but had no effect in Wistar rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: